Adaptive Innovations raises $50M in Series A
Adaptive Innovations has secured a $50 million Series A funding round, led by Felicis, to advance its AI-driven approach to home health care. This funding will enable the company to expand its operations across the U.S., addressing the often inefficient processes in home health service delivery by integrating AI with in-person clinical care. Alongside Felicis, other participants in the round include Optum Ventures, Sunflower Capital, BoxGroup, Dorm Room Fund, Constellation, and several angel investors focused on healthcare and AI.
The company distinguishes itself by being a comprehensive provider rather than a software vendor, embedding AI across its entire operational spectrum—from patient intake to billing. Since its inception in 2025, Adaptive Innovations has rapidly grown to become a key player in Texas's home health sector, catering to over 100,000 patient visits from more than 500 healthcare organizations. By significantly reducing clinician paperwork by 80% and maintaining a rehospitalization rate of 4.9%, which is notably below the industry average, Adaptive’s model demonstrates clear operational efficiencies.
The rationale behind this funding round lies in Adaptive Innovations' aim to overhaul the existing post-acute care framework, which often leaves 40% of prescribed patients without necessary home healthcare due to high administrative costs and coordination complexities. By optimizing these processes with an AI-native platform, Adaptive is managing to decrease costs and accept patients that traditional home health agencies turn away, thereby enhancing patient outcomes and efficiency within the sector.
The broader implications of this development in the healthcare market are significant, as Adaptive Innovations' model challenges the conventional operational structure of home health services. As the demographic shift in the U.S. population increases the demand for skilled nursing care, the sector faces pressure to innovate beyond manual, labor-intensive administrative procedures. Competitors and traditional home health agencies must adapt or risk being overshadowed by AI-efficient models like Adaptive’s.
Looking ahead, the successful deployment and scaling of Adaptive Innovations' technology will be pivotal in determining the industry's direction towards more integrated, AI-powered healthcare solutions. This funding round not only positions the company to expand its footprint but also suggests a trend towards greater capital allocation in AI-based healthcare innovations.
Deal timeline
This transaction is classified in Healthcare with a reported deal value of $50M. Figures and status may change as sources update.